Biogen shares fall after Tecfidera patient dies
October 22, 2014 at 11:48 AM EDT
The patient, who had been taking Tecfidera as part of a clinical trial for 4 1/2 years, died earlier this month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.